190 related articles for article (PubMed ID: 32581150)
21. Cystatin C: a new renal marker and its potential use in small animal medicine.
Ghys L; Paepe D; Smets P; Lefebvre H; Delanghe J; Daminet S
J Vet Intern Med; 2014; 28(4):1152-64. PubMed ID: 24814357
[TBL] [Abstract][Full Text] [Related]
22. Research and diagnostic tool: the symmetric dimethylarginine case-for research use only.
Santoro P
Vet Clin Pathol; 2018 Sep; 47(3):338-339. PubMed ID: 30199123
[No Abstract] [Full Text] [Related]
23. Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents?
Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Michaluk-Skutnik J
Scand J Urol Nephrol; 2012 Feb; 46(1):58-64. PubMed ID: 22017447
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of stable kidney function versus progressive dysfunction in dogs.
Cowgill LD; Segev G; Vaden S; Ross S; Dufayet C; Cohn LA; Nabity M; Farace G; Szlosek D; Ouyang Z; Peterson S; Beall M; Yerramilli M; Polzin D
J Vet Intern Med; 2023; 37(6):2241-2250. PubMed ID: 37861343
[TBL] [Abstract][Full Text] [Related]
25. Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs.
Hall JA; MacLeay J; Yerramilli M; Obare E; Yerramilli M; Schiefelbein H; Paetau-Robinson I; Jewell DE
PLoS One; 2016; 11(4):e0153653. PubMed ID: 27088214
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of serum symmetric dimethylarginine as a biomarker of kidney disease in canine leishmaniosis due to Leishmania infantum.
Giapitzoglou S; Saridomichelakis MN; Leontides LS; Kasabalis D; Chatzis M; Apostolidis K; Theodorou K; Roumpeas E; Mylonakis ME
Vet Parasitol; 2020 Jan; 277():109015. PubMed ID: 31874403
[TBL] [Abstract][Full Text] [Related]
27. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal evaluation of symmetric dimethylarginine and concordance of kidney biomarkers in cats and dogs.
Mack RM; Hegarty E; McCrann DJ; Michael HT; Grauer GF
Vet J; 2021 Oct; 276():105732. PubMed ID: 34391920
[TBL] [Abstract][Full Text] [Related]
29. EVALUATION OF SYMMETRIC DIMETHYLARGININE AS AN EARLY BIOMARKER OF CHRONIC KIDNEY DISEASE IN CAPTIVE CHEETAHS (ACINONYX JUBATUS).
Lamglait B; Vandenbunder-Beltrame M
J Zoo Wildl Med; 2017 Sep; 48(3):874-877. PubMed ID: 28920795
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Renal Biomarkers, Including Symmetric Dimethylarginine, following Gentamicin-Induced Proximal Tubular Injury in the Rat.
Hamlin DM; Schultze AE; Coyne MJ; McCrann DJ; Mack R; Drake C; Murphy RE; Cross J; Strong-Townsend M; Yerramilli M; Leissinger MK
Kidney360; 2022 Feb; 3(2):341-356. PubMed ID: 35373128
[TBL] [Abstract][Full Text] [Related]
31. Kidney Disease and the Nexus of Chronic Kidney Disease and Acute Kidney Injury: The Role of Novel Biomarkers as Early and Accurate Diagnostics.
Yerramilli M; Farace G; Quinn J; Yerramilli M
Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):961-93. PubMed ID: 27485279
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.
Ghys LF; Paepe D; Lefebvre HP; Reynolds BS; Croubels S; Meyer E; Delanghe JR; Daminet S
J Vet Intern Med; 2016 Jul; 30(4):1074-82. PubMed ID: 27461722
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal study on the acceptance and effects of a therapeutic renal food in pet dogs with IRIS-Stage 1 chronic kidney disease.
Hall JA; Fritsch DA; Yerramilli M; Obare E; Yerramilli M; Jewell DE
J Anim Physiol Anim Nutr (Berl); 2018 Feb; 102(1):297-307. PubMed ID: 28276099
[TBL] [Abstract][Full Text] [Related]
34. COMPARISON OF BLOOD SYMMETRIC DIMETHYLARGININE AND CREATININE AS ENDOGENOUS MARKERS OF KIDNEY FUNCTION IN CAPTIVE TIGERS (
Mota SM; Brandão J; Guthrie A
J Zoo Wildl Med; 2021 Jun; 52(2):628-637. PubMed ID: 34130406
[TBL] [Abstract][Full Text] [Related]
35. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
Sinna MM; Altaf FMN; Mosa OF
Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
[TBL] [Abstract][Full Text] [Related]
36. Measurements of echocardiographic indices and biomarkers of kidney injury in dogs with chronic kidney disease.
Hezzell MJ; Foster JD; Oyama MA; Buch J; Farace G; Quinn JJ; Yerramilli M
Vet J; 2020 Jan; 255():105420. PubMed ID: 31982083
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE
J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
[TBL] [Abstract][Full Text] [Related]
38. Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function.
Brans M; Daminet S; Mortier F; Duchateau L; Lefebvre HP; Paepe D
J Vet Intern Med; 2021 Jan; 35(1):303-311. PubMed ID: 33274800
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.
Ji F; Zhang S; Jiang X; Xu Y; Chen Z; Fan Y; Wang W
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27726176
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
Coyne MJ; Schultze AE; McCrann DJ; Murphy RE; Cross J; Strong-Townsend M; Drake C; Mack R
PLoS One; 2022; 17(5):e0269085. PubMed ID: 35622875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
